A Study of LY3039478 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Healthy

Interventions

DRUG

Placebo

Administered orally

DRUG

LY3039478 Capsule Formulation (Formulation 3)

Administered orally

DRUG

LY3039478 Drug-in Capsule (Reference, Formulation 1)

Administered orally

DRUG

LY3039478 Formulated Capsule (Test, Formulation 3)

Administered orally

Trial Locations (1)

Covance, Daytona Beach

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT02659865 - A Study of LY3039478 in Healthy Participants | Biotech Hunter | Biotech Hunter